Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PENTOBARBITAL Cause Multiple-drug resistance? 33 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Multiple-drug resistance have been filed in association with PENTOBARBITAL (Pentobarbital Sodium). This represents 7.4% of all adverse event reports for PENTOBARBITAL.

33
Reports of Multiple-drug resistance with PENTOBARBITAL
7.4%
of all PENTOBARBITAL reports
21
Deaths
21
Hospitalizations

How Dangerous Is Multiple-drug resistance From PENTOBARBITAL?

Of the 33 reports, 21 (63.6%) resulted in death, 21 (63.6%) required hospitalization, and 21 (63.6%) were considered life-threatening.

Is Multiple-drug resistance Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PENTOBARBITAL. However, 33 reports have been filed with the FAERS database.

What Other Side Effects Does PENTOBARBITAL Cause?

Drug ineffective (117) Off label use (101) Toxicity to various agents (76) Drug ineffective for unapproved indication (75) Status epilepticus (59) Completed suicide (49) Metabolic acidosis (42) Drug hypersensitivity (41) Propofol infusion syndrome (36) Shock (35)

What Other Drugs Cause Multiple-drug resistance?

LEVETIRACETAM (1,378) LACOSAMIDE (739) VALPROIC ACID (622) TOPIRAMATE (521) CLOBAZAM (486) LAMOTRIGINE (418) PHENOBARBITAL (406) PHENYTOIN (337) CARBAMAZEPINE (299) PERAMPANEL (258)

Which PENTOBARBITAL Alternatives Have Lower Multiple-drug resistance Risk?

PENTOBARBITAL vs PENTOSAN POLYSULFATE PENTOBARBITAL vs PENTOSTATIN PENTOBARBITAL vs PENTOXIFYLLINE PENTOBARBITAL vs PERAMIVIR PENTOBARBITAL vs PERAMPANEL

Related Pages

PENTOBARBITAL Full Profile All Multiple-drug resistance Reports All Drugs Causing Multiple-drug resistance PENTOBARBITAL Demographics